CardiacAssist, Inc. to Present at Windhover Information and Medtech Insight's ``Investment In Innovation'' Conference.

BOSTON -- CardiacAssist, Inc., with its TandemHeart PTVA System, will be presenting on Thursday, October 21st at Windhover Information and Medtech Insight's Prestigious "Investment In Innovation" Event, taking place October 21-22, 2004 at the Westin Copley Place Hotel in Boston.

CardiacAssist, Inc., a Pittsburgh-based medical device company that develops, manufactures and markets cardiac assist devices, today announced a new milestone by the completion of the 100th U.S. procedure that has helped heart failure patients survive high-risk procedures and other cardiac interventions without undergoing major surgery.

The TandemHeart PTVA System, a percutaneous left ventricular assist device (LVAD) that has received FDA 510(k) clearance late last year for short-term use, helps restore blood circulation through a simple cardiac catheterization procedure. The resulting increase in blood flow helps to save vital organs and gives damaged hearts a chance to heal when patients experience acute, life-threatening heart conditions.

In commenting on the completion of the 100th procedure for this new device, Michael Garippa, President and CEO of CardiacAssist, said: "We are reaching new levels of acceptance every day, as doctors around the country become more familiar with the relative ease of the TandemHeart procedure and how important a medical tool it is. More importantly, the TandemHeart System provides a significant level of care to these critically ill patients."

One of the U.S. Interventional Cardiologists using the TandemHeart System, James R. Revenaugh, MD, FACC, co-director of the Cardiac Cath Lab at LDS Hospital in Salt Lake City, commented: "There is no doubt that this device will continue to be an invaluable tool for the treatment of complex coronary artery disease. We can foresee utility in a number of settings where temporary left ventricular support is necessary. The device, which is relatively simple, can be placed rapidly in the cath lab, and offers effective and reliable temporary circulatory support." Dr. Revenaugh and his team at LDS Hospital performed the 100th U.S. TandemHeart case on July 12, 2004. To date, more than 300 uses of the device in 28 countries at 60 different facilities by 100 different physicians have been performed.

Founded in 1996 by Pittsburgh residents John Marous and Dr. George Magovern, Sr., CardiacAssist, Inc. is a privately held, Pittsburgh-based medical device company that develops, manufactures and markets innovative products designed to provide cardiologists and cardiac surgeons with minimally invasive solutions for treating weakened and failing hearts. Its vision is to help advance the treatment of heart disease by bridging gaps in current treatment methodologics.

About Medtech Insight

Medtech Insight's "Investment In Innovation" conferences are considered the premier forum for senior executives in the investment and medical technology community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. Medtech Insight, which was recently acquired by Windhover Information Inc. (www.windhover.com), publisher of IN VIVO: The Business & Medicine Report, Start-UP: Windhover's Review of Emerging Technologies, and IN VIVO EuropeRx, offers a wide variety of products and services for the medical technology executive. In addition to conferences, the company publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, as well as analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the Boston conference or for more information on Medtech Insight, please call Scott Pantel at 949-219-0150 or 888-290-2225 toll-free in the U.S., e-mail [e-mail], or visit http://www.medtechinsight.com/in3-12.html.